跳至主要内容
临床试验/NCT03145870
NCT03145870撤回不适用

Prevalence of Asymptomatic Thrombosis in Multiple Myeloma

Centre Hospitalier Universitaire, Amiens2 个研究点 分布在 1 个国家开始时间: 2014年6月3日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Analysis of the occurrence of venous thromboembolic events via transverse Doppler echo

研究概览

简要总结

Malignant hemopathies, such as solid cancers, increase the risk of venous and arterial thromboembolic events. The incidence of symptomatic venous thromboembolic events is particularly high in myeloma, linked to the usual risk factors for venous thromboembolic disease, biological risk factors specific to myeloma, and especially to its treatments.

The prevalence of asymptomatic venous thromboembolic events and arterial events are not known to date and remain important data for planning a possible randomized study to determine the most suitable thromboprophylaxis in these patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient major age ≥18 years
  • Patients with symptomatic myeloma meeting the definition of the International Myeloma Working Group, regardless of the therapeutic line, including patients in remission and untreated.
  • Patient having given informed consent, signed.
  • Patient benefiting from a social security scheme

排除标准

  • Patients with non-symptomatic myeloma (stage I) or gammapathy of unknown significance (MGUS).
  • Patient undergoing antithrombotic treatment for deep or superficial venous thrombosis and / or pulmonary embolism at the time of inclusion.
  • Patients with occlusive arterial disease of the lower limbs known at the time of inclusion.
  • Minors, protected adults and patients deprived of liberty or not affiliated to a social security scheme
  • Pregnant woman
  • Patient unable to express consent.
  • Patient under guardianship or curatorship or patient deprived of public liberty

结局指标

主要结局

Analysis of the occurrence of venous thromboembolic events via transverse Doppler echo

时间窗: 1 day

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Prevalence of Asymptomatic Thrombosis in Multiple... | 临床试验